(NYSE: STE) Steris's forecast annual revenue growth rate of 6.18% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Steris's revenue in 2025 is $5,571,113,000.On average, 3 Wall Street analysts forecast STE's revenue for 2026 to be $582,358,111,384, with the lowest STE revenue forecast at $579,709,797,480, and the highest STE revenue forecast at $584,802,451,244. On average, 3 Wall Street analysts forecast STE's revenue for 2027 to be $616,150,730,756, with the lowest STE revenue forecast at $604,676,181,195, and the highest STE revenue forecast at $622,408,626,880.
In 2028, STE is forecast to generate $659,019,850,414 in revenue, with the lowest revenue forecast at $653,085,298,950 and the highest revenue forecast at $664,954,500,369.